Public Profile

Zymeworks Inc.

Zymeworks Inc., a leading biotechnology company headquartered in the United States, specialises in the development of innovative therapeutic solutions for cancer and other serious diseases. Founded in 2003, Zymeworks has established itself as a pioneer in the field of protein engineering, particularly through its proprietary ZymeLink™ and Zymeworks' Azymetric™ platforms, which enable the creation of multifunctional therapeutics. With a strong presence in North America and expanding operations in Europe and Asia, Zymeworks focuses on advancing its pipeline of bispecific antibodies and antibody-drug conjugates. The company has achieved significant milestones, including strategic partnerships with major pharmaceutical firms, positioning itself as a key player in the biopharmaceutical industry. Zymeworks' commitment to innovation and excellence continues to drive its success in delivering unique, targeted therapies that address unmet medical needs.

DitchCarbon Score

How does Zymeworks Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

18

Industry Average

Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

2

Industry Benchmark

Zymeworks Inc.'s score of 18 is higher than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.

84%

Zymeworks Inc.'s reported carbon emissions

Zymeworks Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor specific reduction targets or climate commitments outlined in their initiatives. Without concrete figures or defined goals, it is challenging to assess their carbon footprint or climate strategy. However, as a company operating in the biopharmaceutical sector, Zymeworks is likely aware of the increasing importance of sustainability and may be exploring avenues to align with industry standards for emissions reduction and climate action. Further information on their commitments or initiatives may be necessary to provide a comprehensive overview of their environmental impact.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Zymeworks Inc.'s primary industry is Health and social work services (85), which is low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. Zymeworks Inc. is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Zymeworks Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
Carbon Disclosure Project
The Climate Pledge
UN Global Compact

Similar Organizations

Abbvie

US
Chemicals nec
Updated 1 day ago

Ablexis, LLC

US
Health and social work services (85)
Updated 6 days ago

Specifica

NL
Bricks, tiles and construction products, in baked clay
Updated 6 days ago

Adimab

US
Chemicals nec
Updated 6 days ago

Genovac AG

DE
Updated 6 days ago
DitchCarbon Score

Genmab

DK
Medical, precision and optical instruments, watches and clocks (33)
Updated about 20 hours ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers